
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc. is positioned to gain significantly from the anticipated stronger Medicare Advantage (MA) rate update in 2026, particularly as many managed care organizations are scaling back benefits while Alignment Healthcare retains a competitive Stars funding advantage. The company's integrated MA-VBC model is expected to facilitate long-term market share expansion and above-average growth through effective health outcomes. Additionally, gross profit per member per month (PMPM) for the initial cohorts is projected to range between $90-$150, increasing to over $230 PMPM by the latter years, suggesting a solid profitability trajectory as the company's membership scales.
Bears say
Alignment Healthcare's stock outlook is negatively influenced by challenges in realizing consistent results through its value-based care (VBC) model, which faces data friction across varying payors. Despite achieving lower Annualized Disenrollment Rate (ADK) during periods of heightened healthcare utilization, the complexities associated with its operational model and technology platform may detract from long-term financial stability. Additionally, although the company's valuation multiple is slightly above the long-term range for peer managed care organizations, persistent operational hurdles could hinder sustainable EBITDA growth and overall performance.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares